» Articles » PMID: 20833209

Biochemical Characterization of Plasmodium Falciparum Dipeptidyl Aminopeptidase 1

Overview
Date 2010 Sep 14
PMID 20833209
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Dipeptidyl aminopeptidase 1 (DPAP1) is an essential food vacuole enzyme with a putative role in hemoglobin catabolism by the erythrocytic malaria parasite. Here, the biochemical properties of DPAP1 have been investigated and compared to those of the human ortholog cathepsin C. To facilitate the characterization of DPAP1, we have developed a method for the production of purified recombinant DPAP1 with properties closely resembling those of the native enzyme. Like cathepsin C, DPAP1 is a chloride-activated enzyme that is most efficient in catalyzing amide bond hydrolysis at acidic pH values. The monomeric quaternary structure of DPAP1 differs from the homotetrameric structure of cathepsin C, which suggests that tetramerization is required for a cathepsin C-specific function. The S1 and S2 subsite preferences of DPAP1 and cathepsin C were profiled with a positional scanning synthetic combinatorial library. The S1 preferences bore close similarity to those of other C1-family cysteine peptidases. The S2 subsites of both DPAP1 and cathepsin C accepted aliphatic hydrophobic residues, proline, and some polar residues, yielding a distinct specificity profile. DPAP1 efficiently catalyzed the hydrolysis of several fluorogenic dipeptide substrates; surprisingly, however, a potential substrate with a P2-phenylalanine residue was instead a competitive inhibitor. Together, our biochemical data suggest that DPAP1 accelerates the production of amino acids from hemoglobin by bridging the gap between the endopeptidase and aminopeptidase activities of the food vacuole. Two reversible cathepsin C inhibitors potently inhibited both recombinant and native DPAP1, thereby validating the use of recombinant DPAP1 for future inhibitor discovery and characterization.

Citing Articles

Evolutionary Analysis of Dipeptidyl Peptidase I.

Varda N, Novinec M Int J Mol Sci. 2022; 23(3).

PMID: 35163774 PMC: 8836896. DOI: 10.3390/ijms23031852.


Identification of Plasmodium dipeptidyl aminopeptidase allosteric inhibitors by high throughput screening.

Sanchez M, de Vries L, Lehmann C, Lee J, Ang K, Wilson C PLoS One. 2019; 14(12):e0226270.

PMID: 31851699 PMC: 6919601. DOI: 10.1371/journal.pone.0226270.


Characterization of P. falciparum dipeptidyl aminopeptidase 3 specificity identifies differences in amino acid preferences between peptide-based substrates and covalent inhibitors.

de Vries L, Sanchez M, Groborz K, Kuppens L, Poreba M, Lehmann C FEBS J. 2019; 286(20):3998-4023.

PMID: 31177613 PMC: 6851853. DOI: 10.1111/febs.14953.


Biguanide is a modifiable pharmacophore for recruitment of endogenous Zn to inhibit cysteinyl cathepsins: review and implications.

Lockwood T Biometals. 2019; 32(4):575-593.

PMID: 31044334 PMC: 6647370. DOI: 10.1007/s10534-019-00197-1.


Evidence for Regulation of Hemoglobin Metabolism and Intracellular Ionic Flux by the Plasmodium falciparum Chloroquine Resistance Transporter.

Lee A, Dhingra S, Lewis I, Singh M, Siriwardana A, Dalal S Sci Rep. 2018; 8(1):13578.

PMID: 30206341 PMC: 6134138. DOI: 10.1038/s41598-018-31715-9.


References
1.
McDonald J, Reilly T, ZEITMAN B, Ellis S . Cathepsin C: a chloride-requiring enzyme. Biochem Biophys Res Commun. 1966; 24(5):771-5. DOI: 10.1016/0006-291x(66)90392-5. View

2.
Krugliak M, Zhang J, Ginsburg H . Intraerythrocytic Plasmodium falciparum utilizes only a fraction of the amino acids derived from the digestion of host cell cytosol for the biosynthesis of its proteins. Mol Biochem Parasitol. 2002; 119(2):249-56. DOI: 10.1016/s0166-6851(01)00427-3. View

3.
Bondebjerg J, Fuglsang H, Valeur K, Kaznelson D, Hansen J, Pedersen R . Novel semicarbazide-derived inhibitors of human dipeptidyl peptidase I (hDPPI). Bioorg Med Chem. 2005; 13(14):4408-24. DOI: 10.1016/j.bmc.2005.04.048. View

4.
Bondebjerg J, Fuglsang H, Valeur K, Pedersen J, Naerum L . Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors. Bioorg Med Chem Lett. 2006; 16(13):3614-7. DOI: 10.1016/j.bmcl.2006.01.102. View

5.
Bennett T, Kosar A, Ursos L, Dzekunov S, Sidhu A, Fidock D . Drug resistance-associated pfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH. Mol Biochem Parasitol. 2003; 133(1):99-114. DOI: 10.1016/j.molbiopara.2003.09.008. View